A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies
The Journal of Immunology · 15.04.2023 · 210 (8) · 1166-1176
DOI: 10.4049/jimmunol.2200597 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 01.03.2023. Verfasst von Daniel D Bravo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA. Hauptthemen laut MEDLINE: Apoptosis, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Efferocytosis is a phagocytic process by which apoptotic cells are cleared by professional and nonprofessional phagocytic cells. In tumors, efferocytosis of apoptotic cancer cells by tumor-associated macrophages prevents Ag presentation and suppresses the host immune response against the tumor. Therefore, reactivating the immune response by blockade of tumor-associated macrophage–mediated efferocytosis is an attractive strategy for cancer immunotherapy. Even though several methods have been developed to monitor efferocytosis, an automated and high-throughput quantitative assay should offer highly desirable advantages for drug discovery. In this study, we describe a real-time efferocytosis assay with an imaging system for live-cell analysis. Using this assay, we successfully discovered potent anti-MerTK Abs that block tumor-associated macrophage–mediated efferocytosis in mice. Furthermore, we used primary human and cynomolgus monkey macrophages to identify and characterize anti-MerTK Abs for potential clinical development. By studying the phagocytic activities of different types of macrophages, we demonstrated that our efferocytosis assay is robust for screening and characterization of drug candidates that inhibit unwanted efferocytosis. Moreover, our assay is also applicable to investigating the kinetics and molecular mechanisms of efferocytosis/phagocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA.
- Department of Molecular and Cellular Biology, University of California, Berkeley, Berkeley, CA.
- Department of Antibody Engineering, Genentech, Inc., South San Francisco, CA.
- Department of Molecular Oncology, Genentech, Inc., South San Francisco, CA.
ORCID-Profile: Yongchang Shi, Allison Sheu, Jianyong Wang
Zitieren
APA
Bravo, D. D., Shi, Y., Sheu, A., Liang, W. C., Lin, W., Wu, Y., Yan, M., & Wang, J. (2023). A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies. The Journal of Immunology, 210(8), 1166-1176. https://doi.org/10.4049/jimmunol.2200597
Vancouver
Bravo DD, Shi Y, Sheu A, Liang WC, Lin W, Wu Y, et al. A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies. The Journal of Immunology. 2023;210(8):1166-1176. doi:10.4049/jimmunol.2200597
BibTeX
@article{Bravo2023,
author = {Bravo, Daniel D and Shi, Yongchang and Sheu, Allison and Liang, Wei-Ching and Lin, WeiYu and Wu, Yan and Yan, Minhong and Wang, Jianyong},
title = {A Real-Time Image-Based Efferocytosis Assay for the Discovery of Functionally Inhibitory Anti-MerTK Antibodies},
journal = {The Journal of Immunology},
year = {2023},
volume = {210},
number = {8},
pages = {1166--1176},
doi = {10.4049/jimmunol.2200597}
}
EUVIMED